PUBLICATION

High-Throughput Automated Phenotyping of Two Genetic Mouse Models of Huntington’s Disease.

July 26, 2013

PUBLICATION

Regional Vulnerability in Huntington’s disease: fMRI-guided Molecular Analysis in Patients and a Mouse Model of disease

April 1, 2013

PUBLICATION

Comprehensive Behavioral and Molecular characterization of a new knock-in Mouse Model of Huntington’s disease: zQ175

October 26, 2012

PUBLICATION

Insights into the Structural Determinants Required for High Affinity Binding of Chiral Cyclopropane-Containing Ligands to α4β2-Nicotinic Acetylcholine Receptors; An Integrated Approach to Behaviorally Active Nicotinic Ligands.

October 25, 2012

PUBLICATION

Functional Improvement in Mouse Models of Familial Amyotrophic Lateral Sclerosis by PEGylated insulin-like Growth Factor I Treatment Depends on Disease Severity .

September 26, 2012

PUBLICATION

Prediction of Death in the SMNΔ Mouse Model of Spinal Muscular Atrophy: Insight into Disease Stage and Progression. Journal of Neuroscience Methods.

August 29, 2012

PUBLICATION

Identification of a Maleimide-Based Glycogen Synthase Kinase-3 (GSK-3) Inhibitor, BIP-135, that Prolongs the Median Survival Time of Ä7 SMA KO Mouse Model of Spinal Muscular Atrophy.

June 29, 2012

PUBLICATION

Effect of the Rd1 Mutation on Motor Performance in R6/2 and Wild Type Mice. PLoS Currents Huntington Disease.

June 28, 2012

PUBLICATION

Identification of Novel alpha4 beta2-Nicotinic Acetylcholine Receptor (nAChR) Agonists Based on an Isoxazole Ether Scaffold that Demonstrate Antidepressant-like Activity. Journal of medicinal chemistry.

June 27, 2012